What is NDC 76282-627?

76282-627 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Exelan Pharmaceuticals, Inc.. It has 7 package NDCs, shown above in 10- and 11-digit form.

Exelan Pharmaceuticals, Inc., NDC labeler code 76282. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 76282-627 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)76282-627Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76282-0627Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
76282-627-01	7628206270176282062701	100 CAPSULE in 1 BOTTLE (76282-627-01)Marketed from Sep 13, 2018
76282-627-05	7628206270576282062705	500 CAPSULE in 1 BOTTLE (76282-627-05)Marketed from Sep 13, 2018
76282-627-18	7628206271876282062718	180 CAPSULE in 1 BOTTLE (76282-627-18)Marketed from Sep 13, 2018
76282-627-27	7628206272776282062727	270 CAPSULE in 1 BOTTLE (76282-627-27)Marketed from Sep 13, 2018
76282-627-30	7628206273076282062730	30 CAPSULE in 1 BOTTLE (76282-627-30)Marketed from Sep 13, 2018
76282-627-60	7628206276076282062760	60 CAPSULE in 1 BOTTLE (76282-627-60)Marketed from Sep 13, 2018
76282-627-90	7628206279076282062790	90 CAPSULE in 1 BOTTLE (76282-627-90)Marketed from Sep 13, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Exelan Pharmaceuticals, Inc.NDC labeler code 76282
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090705
Marketing start: Sep 13, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 76282-627_5e0a57d7-9068-43d3-be26-96f646720fdeSPL ID 5e0a57d7-9068-43d3-be26-96f646720fdeSPL set ID 41d1ead3-046e-4abf-ae0a-cb126a1f5848RxCUI 310430, 310431, 310432UNII 6CW7F3G59XUPC 0376282323909, 0376282627182, 0376282323053, 0376282321189, 0376282627304, 0376282627908, 0376282627601, 0376282323275, 0376282321271, 0376282321059, 0376282321905, 0376282323015, 0376282321011, 0376282627274, 0376282627014

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476282062701 followed by a unit qualifier and the quantity

Package 76282-0627-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2025.

Indications (excerpt from the label)

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 76282-627

What is NDC 76282-627?: 76282-627 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Exelan Pharmaceuticals, Inc.. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Exelan Pharmaceuticals, Inc., NDC labeler code 76282. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-00
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 090705

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090705
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cipla USA Inc.	69097-943
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Asclemed USA, Inc.	76420-020
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-166
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-185
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0073
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Proficient Rx LP	63187-909
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4261
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Cipla USA Inc.	69097-815
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cipla USA Inc.	69097-813
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1454
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1453
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Proficient Rx LP	63187-392
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Exelan Pharmaceuticals, Inc.	76282-321
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Exelan Pharmaceuticals, Inc.	76282-323